PureTech startup snags $100M for its new approach to treating depression

The latest stories trending on MedCity News.

Editor's Pick

Top Story PureTech Startup Gets $100M to Try For Success Where Sage & Others Fall Short in Depression Seaport Therapeutics' drug candidates are delivered through the lymphatic system, an approach that could overcome some limitations of neuropsychiatric medicines, including products from Sage Therapeutics. The startup stems from the research of PureTech Health. These Startups Will Present At INVEST 2024 Have you heard? The following startups are the selected finalists for the payer/provider track at INVEST 2024: Samaritan, Syntax Health, Somnea Health, Healcisio, Kemtai, and DNASafe. Their health tech solutions span a wide range of areas such as physical therapy, critical illness, health data privacy, as well as solutions to burnout and operational efficiency and more. Join us May 21-22 and create opportunities. Get Your Tickets Now

Featured News

Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability. How Can Healthcare Ensure Responsible AI Use? At a recent conference, executives from across the industry shared their thoughts on how the healthcare sector can ensure its use of AI is ethical and responsible. They highlighted the need for collaboration, trust building and pragmatic thinking. Pelago Unveils Contingency Management Program To Support Those With Substance Use Disorder Pelago's new contingency management program rewards patients for engaging in treatment, such as completing a survey, completing app check-ins, attending appointments and completing cognitive behavioral therapy exercises.

Resources

A Conversation About Wearable Robots with Scott Davis In this final episode of Season 1, which focuses on the world of medtech, Scott Davis, CEO of Ekso Bionics, delves into the history of the company and the novel devices that Ekso has built. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe